These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16198036)

  • 1. Genetic susceptibility testing from a stress and coping perspective.
    Gooding HC; Organista K; Burack J; Biesecker BB
    Soc Sci Med; 2006 Apr; 62(8):1880-90. PubMed ID: 16198036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A theoretical psychological perspective on predictive testing for late onset hereditary diseases.
    Mularczyk E; Decruyenaere M; Denayer L; Evers-Kiebooms G
    Genet Couns; 2007; 18(4):367-78. PubMed ID: 18286817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coping with genetic testing for breast cancer susceptibility.
    Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
    Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Psychooncology; 2007 Dec; 16(12):1121-9. PubMed ID: 17328098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A literature review of the psychological impact of genetic testing on breast cancer patients.
    Schlich-Bakker KJ; ten Kroode HF; Ausems MG
    Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological impact of genetic testing for adult-onset disorders. An update for clinicians.
    Meiser B; Gleeson MA; Tucker KM
    Med J Aust; 2000 Feb; 172(3):126-9. PubMed ID: 10735024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research.
    Marteau TM; Weinman J
    Soc Sci Med; 2006 Mar; 62(6):1360-8. PubMed ID: 16162383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychosocial consequences of genetic susceptibility on development of disease].
    Tobiasz-Adamczyk B
    Przegl Lek; 2005; 62(12):1521-4. PubMed ID: 16786787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of a brief self-help coping intervention designed to reduce distress when awaiting genetic risk information.
    Bennett P; Phelps C; Brain K; Hood K; Gray J
    J Psychosom Res; 2007 Jul; 63(1):59-64. PubMed ID: 17586338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Theory of Genetic Vulnerability: a Roy model exemplar.
    Hamilton RJ; Bowers BJ
    Nurs Sci Q; 2007 Jul; 20(3):254-64. PubMed ID: 17595406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Living with the uncertainty of developing cancer].
    Murphy AE
    Soins; 1999 May; (635):29-31. PubMed ID: 10595219
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations.
    d'Agincourt-Canning L; Baird P
    Crit Rev Oncol Hematol; 2006 May; 58(2):114-23. PubMed ID: 16600617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
    Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
    Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.
    O'Neill SC; DeMarco T; Peshkin BN; Rogers S; Rispoli J; Brown K; Valdimarsdottir H; Schwartz MD
    Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):251-9. PubMed ID: 17024668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of living with a strong family history of breast cancer.
    Maheu C
    Can J Nurs Res; 2009 Jun; 41(2):100-12. PubMed ID: 19650516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive testing for Huntington's disease.
    Tibben A
    Brain Res Bull; 2007 Apr; 72(2-3):165-71. PubMed ID: 17352941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
    Lewis MJ; Peterson SK
    Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
    Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
    Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.